As capital sources become more elusive, companies are increasingly exploring creative methods to structure transactions and it is more important than ever to find successful transaction structures that build value. This session will focus on unique financial structures that have been utilized to leverage industry and financing opportunities.
This panel will review the following:
Combined deferred mergers and product development licenses
Debt transactions
Equity lines
The use of business incubators
Moderator:
- Richard A. Kaufman, Partner, Foley & Lardner
Panelists:
- Mark Benedyk, Head of The Pfizer Incubator LLC
- Donna Tempel, Ph.D., President and CEO, Drais Pharmaceuticals
- Jack Lief, Co-Founder, Chairman, President & CEO, Arena Pharmaceuticals
- Michael White, Deal Team Leader, Silicon Valley Bank
Related Insights
July 8, 2025
Energy Current
What’s the Future for Renewable Energy Tax Credits in Congress?
The One Big Beautiful Bill Act (OBBB) has a significant impact on the renewable energy sector, particularly with changes in the phase-out…
July 8, 2025
Energy Current
Executive Order on PTC and ITC Beginning of Construction
President Trump yesterday issued an executive order, “Ending Market Distorting Subsidies for Unreliable, Foreign Controlled Energy…
July 8, 2025
Foley Viewpoints
The HDHP Telehealth Safe Harbor Returns – For Good This Time
President Trump signed into law the One Big Beautiful Bill Act (the bill) on July 4, 2025. The telehealth safe harbor, which allowed…